Director Dermot Durcan adds 4,000 Cencora (NYSE: COR) shares

Rhea-AI Filing Summary

Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of 4,000 shares of Common Stock on 2026-05-28 at an average price of $266.26 per share. Following this transaction, he directly owns 27,767 Cencora shares.

Insider Trade Summary

Net Buyer: 4,000 shares ($1,065,040)

Net Buy 1 txn

Insider DURCAN DERMOT MARK

Role null

Bought 4,000 shs ($1.07M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,000	$266.26	$1.07M

Holdings After Transaction: Common Stock — 27,767 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 4,000 shares Purchase price: $266.26 per share Post-transaction holdings: 27,767 shares +1 more

4 metrics

Shares purchased 4,000 shares Open-market Common Stock buy

Purchase price $266.26 per share Average price on 2026-05-28

Post-transaction holdings 27,767 shares Directly owned after trade

Net buy shares 4,000 shares Net of buys and sells in this filing

Key Terms

open-market purchase, Common Stock, Form 4

3 terms

open-market purchase financial

"reported an open-market purchase of 4,000 shares of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"reported an open-market purchase of 4,000 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"Cencora reported that director Dermot Mark Durcan made an open-market purchase of 4,000 shares of Common Stock. The trade was executed at an average price of $266.26 per share and increased his directly held stake to 27,767 shares."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DURCAN DERMOT MARK

(Last) (First) (Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		P		4,000	A	$266.26	27,767	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for D. Mark Durcan	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cencora (COR) disclose in this Form 4?

Cencora reported that director Dermot Mark Durcan made an open-market purchase of 4,000 shares of Common Stock. The trade was executed at an average price of $266.26 per share and increased his directly held stake to 27,767 shares.

Who is the insider buying Cencora (COR) shares and what is their role?

The buyer is Dermot Mark Durcan, a director of Cencora, Inc. According to the Form 4, he is not listed as an officer or 10% owner. His open-market purchase adds to his existing board-level equity position in the company.

How many Cencora (COR) shares did the director buy and at what price?

The director purchased 4,000 shares of Cencora Common Stock in an open-market transaction. The filing reports an average purchase price of $266.26 per share, representing a total cash outlay of roughly $1.07 million for this single trade.

What are Dermot Mark Durcan’s Cencora (COR) holdings after the transaction?

After the reported purchase, Dermot Mark Durcan directly owns 27,767 Cencora shares. This figure, disclosed in the Form 4, reflects his updated beneficial ownership of the company’s Common Stock immediately following the 4,000-share open-market transaction.

Was the Cencora (COR) insider transaction a buy or a sell?

The Form 4 shows a buy transaction. It is coded as “P,” described as an open-market or private purchase, with 4,000 Cencora Common Stock shares acquired at $266.26 per share and no reported sales or derivative exercises in this filing.

Does this Cencora (COR) Form 4 involve any stock options or derivatives?

No, this filing only reports a non-derivative Common Stock purchase. The derivative summary section is empty, indicating there were no option exercises, conversions, or other derivative-related transactions associated with this particular Form 4 disclosure.